dc.contributor.author
Swolinsky, Jutta S.
dc.contributor.author
Nerger, Niklas P.
dc.contributor.author
Leistner, David M.
dc.contributor.author
Edelmann, Frank
dc.contributor.author
Knebel, Fabian
dc.contributor.author
Tuvshinbat, Enkhtuvshin
dc.contributor.author
Lemke, Caroline
dc.contributor.author
Roehle, Robert
dc.contributor.author
Haase, Michael
dc.contributor.author
Costanzo, Maria Rosa
dc.contributor.author
Rauch, Geraldine
dc.contributor.author
Mitrovic, Veselin
dc.contributor.author
Gasanin, Edis
dc.contributor.author
Meier, Daniel
dc.contributor.author
McCullough, Peter A.
dc.contributor.author
Eckardt, Kai‐Uwe
dc.contributor.author
Molitoris, Bruce A.
dc.contributor.author
Schmidt‐Ott, Kai M.
dc.date.accessioned
2022-11-03T15:57:51Z
dc.date.available
2022-11-03T15:57:51Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/36698
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-36411
dc.description.abstract
Aims: We aimed to test whether the endogenous filtration markers serum creatinine or cystatin C and equation-based estimates of glomerular filtration rate (GFR) based on these markers appropriately reflect changes of measured GFR in patients with acute heart failure.
Methods: In this prospective cohort study of 50 hospitalized acute heart failure patients undergoing decongestive therapy, we applied an intravenous visible fluorescent injectate (VFI), consisting of a low molecular weight component to measure GFR and a high molecular weight component to correct for measured plasma volume. Thirty-eight patients had two sequential GFR measurements 48 h apart. The co-primary endpoints of the study were safety of VFI and plasma stability of the high molecular weight component. A key secondary endpoint was to compare changes in measured GFR (mGFR) to changes of serum creatinine, cystatin C and estimated GFR.
Results: VFI-based GFR measurements were safe and consistent with plasma stability of the high molecular weight component and glomerular filtration of the low molecular weight component. Filtration marker-based point estimates of GFR, when compared with mGFR, provided only moderate correlation (Pearson's r, range 0.80-0.88, depending on equation used), precision (r(2), range 0.65-0.78) and accuracy (56%-74% of estimates scored within 30% of mGFR). Correlations of 48-h changes GFR estimates and changes of mGFR were significant (P < 0.05) but weak (Pearson's r, range 0.35-0.39). Observed decreases of eGFR by more than 15% had a low sensitivity (range 38%-46%, depending on equation used) in detecting true worsening mGFR, defined by a >15% decrease in mGFR.
Conclusions: In patients hospitalized for acute heart failure, serum creatinine- and cystatin C-based predictions performed poorly in detecting actual changes of GFR. These data challenge current clinical strategies to evaluate dynamics of kidney function in acute heart failure.
en
dc.rights.uri
https://creativecommons.org/licenses/by-nc/4.0/
dc.subject
Acute heart failure
en
dc.subject
Worsening kidney function
en
dc.subject
Acute kidney injury
en
dc.subject
CKD-EPI formula
en
dc.subject
Measured GFR
en
dc.subject
Visible fluorescent injectate
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failure
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1002/ehf2.13404
dcterms.bibliographicCitation.journaltitle
ESC Heart Failure
dcterms.bibliographicCitation.number
4
dcterms.bibliographicCitation.originalpublishername
Wiley
dcterms.bibliographicCitation.pagestart
3070
dcterms.bibliographicCitation.pageend
3081
dcterms.bibliographicCitation.volume
8
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
DEAL Wiley
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
33955699
dcterms.isPartOf.eissn
2055-5822